| Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis MH Kuo, CW Tseng, CH Lee, CH Tung, KC Tseng, NS Lai Scientific Reports 10 (1), 2456, 2020 | 38 | 2020 |
| Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing tocilizumab-containing treatment MH Kuo, CW Tseng, MC Lu, CH Tung, KC Tseng, KY Huang, CH Lee, ... Digestive diseases and sciences, 1-9, 2021 | 28 | 2021 |
| Drug-drug interactions between direct-acting antivirals and statins in the treatment of chronic hepatitis C MH Kuo, CW Tseng, CH Lee, KC Tseng Tzu Chi Medical Journal 32 (4), 331-338, 2020 | 6 | 2020 |
| Prevalence and effect of low skeletal muscle mass among hepatocellular carcinoma patients undergoing systemic therapy: a systematic review and meta-analysis MH Kuo, CW Tseng, CS Hsu, YC Chen, IT Kao, CY Wu, SC Shao Cancers 15 (9), 2426, 2023 | 3 | 2023 |
| Identification and management of contraindicated drug–drug interactions through pharmaceutical care programs: Experience in direct-acting antivirals therapy MH Kuo, CW Tseng, CH Lee, YC Yang, HJ Wu, HJ Lin, YL Chu, YC Chen, ... Journal of the Formosan Medical Association 121 (1), 58-65, 2022 | 2 | 2022 |
| HBV reactivation in HBsAg−/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs MH Kuo, CW Tseng, PH Ko, ST Wang, MC Lu, CH Tung, KC Tseng, ... Liver International 44 (2), 497-507, 2024 | 1 | 2024 |
| Impact of Low Muscle Mass on Hepatocellular Carcinoma Patients Undergoing Transcatheter Liver-Directed Therapies: Systematic Review & Meta-Analysis YC Chen, MH Kuo, CS Hsu, IT Kao, CY Wu, CW Tseng, SC Shao Cancers 16 (2), 319, 2024 | | 2024 |
| The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis PH Ko, MH Kuo, IT Kao, CY Wu, CW Tseng, SC Shao Viruses 16 (1), 78, 2024 | | 2024 |
| Incidence of hepatitis B virus reactivation in patients with psoriasis treated with cytokine inhibitors MH Kuo, CW Tseng, SC Shao Alimentary Pharmacology & Therapeutics 58 (8), 850-851, 2023 | | 2023 |
| MODERATE RISK OF HEPATITIS B VIRUS REACTIVATION IN HBsAg (-)/HBcAb (+) CARRIERS RECEIVING RITUXIMAB FOR RHEUMATOID ARTHRITIS MH Kuo, CW Tseng, CH Lee HEPATOLOGY 70, 624A-624A, 2019 | | 2019 |
Chih-wei TsengDalin Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationVerified email at tzuchi.com.tw
